Phase I trial erlotinib, gemcitabine, and the hedgehog inhibitor, GDC-0449. This is an ASCO Meeting Abstract from the 2011 ASCO Annual Meeting I. This abstract does not include a full text component.
Fms and Kit are kinases integral to the function of macrophages and mast cells, respectively, and have been shown to play roles in processes in cancer involving proliferation and metastasis. We have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback